79 related articles for article (PubMed ID: 25691727)
1. Session 4: overall integrated viral clearance and adventitious agents strategy.
Blümel J; Tounekti O
PDA J Pharm Sci Technol; 2015; 69(1):195-205. PubMed ID: 25691727
[No Abstract] [Full Text] [Related]
2. Session 2/3: integrated viral clearance strategy and case studies.
Willkommen H
PDA J Pharm Sci Technol; 2015; 69(1):183-94. PubMed ID: 25691726
[No Abstract] [Full Text] [Related]
3. 2013 viral clearance symposia - session 5. Conference summary: key discussion and outcomes, pending questions, and proposed experiments.
Blümel J; Roush D
PDA J Pharm Sci Technol; 2015; 69(1):206-10. PubMed ID: 25691728
[No Abstract] [Full Text] [Related]
4. Viral clearance using traditional, well-understood unit operations: session 1.2. Anion exchange chromatography; and session 1.3. Protein a chromatography.
Roush D
PDA J Pharm Sci Technol; 2015; 69(1):154-62. PubMed ID: 25691723
[No Abstract] [Full Text] [Related]
5. Session 1.5: other viral clearance and inactivation approaches (multimodal chromatography, membrane chromatography, chemical precipitation).
Hubbard B
PDA J Pharm Sci Technol; 2015; 69(1):173-82. PubMed ID: 25691725
[No Abstract] [Full Text] [Related]
6. Viral clearance of traditional unit operations: virus-retentive filtration.
Chen Q; Chen D
PDA J Pharm Sci Technol; 2015; 69(1):142-53. PubMed ID: 25691722
[No Abstract] [Full Text] [Related]
7. Proceedings of the 2013 Viral Clearance Symposium (Princeton, NJ).
Roush D; Brorson K; Levy R
PDA J Pharm Sci Technol; 2015; 69(1):140-1. PubMed ID: 25691721
[No Abstract] [Full Text] [Related]
8. Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.
Mori S; Miyake S; Kobe T; Nakaya T; Fuller SD; Kato N; Kaihatsu K
Bioorg Med Chem Lett; 2008 Jul; 18(14):4249-52. PubMed ID: 18547804
[TBL] [Abstract][Full Text] [Related]
9. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
10. Cell metabolism of acyclovir phosphonate derivatives and antiherpesvirus activity of their combinations with alpha2-interferon.
Skoblov YS; Karpenko IL; Jasko MV; Kukhanova MK; Andronova VL; Galegov GA; Sidorov GV; Myasoedov NF
Chem Biol Drug Des; 2007 Jun; 69(6):429-34. PubMed ID: 17581237
[TBL] [Abstract][Full Text] [Related]
11. Antiviral and Immunomodulatory Effects of Norantea brasiliensis Choisy on Dengue Virus-2.
Fialho LG; da Silva VP; Reis SR; Azeredo EL; Kaplan MA; Figueiredo MR; Kubelka CF
Intervirology; 2016; 59(4):217-227. PubMed ID: 28329744
[TBL] [Abstract][Full Text] [Related]
12. [Antiviral activity of aqueous extracts and polysaccharide fractions from mycelium and fruit bodies of higher fungi].
Razumov IA; Kosogova TA; Kazachinskaia EI; Puchkova LI; Shcherbakova NS; Gorbunova IA; Mikhaĭlovskaia IN; Loktev VB; Tepliakova TV
Antibiot Khimioter; 2010; 55(9-10):14-8. PubMed ID: 21400748
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity of Ergoferon against Group A Rotavirus.
Emelianova AG; Shilovskii IP; Sundukova MS; Khaitov MR; Epshtein OI
Bull Exp Biol Med; 2016 Oct; 161(6):806-807. PubMed ID: 27783292
[TBL] [Abstract][Full Text] [Related]
14. [Pegylated interferons: pharmacological basis].
Macquin-Mavier I; Hezode C; Dhumeaux D
Gastroenterol Clin Biol; 2002; 26(8-9):742-7. PubMed ID: 12434079
[No Abstract] [Full Text] [Related]
15. Synthesis of nucleoside-based antiviral drugs in ionic liquids.
Kumar V; Malhotra SV
Bioorg Med Chem Lett; 2008 Oct; 18(20):5640-2. PubMed ID: 18796352
[TBL] [Abstract][Full Text] [Related]
16. Conversion of 3-arylazo-5-phenyl-2(3H)-furanones into other heterocycles of anticipated biological activity.
Sayed HH; Hashem AI; Yousif NM; El-Sayed WA
Arch Pharm (Weinheim); 2007 Jun; 340(6):315-9. PubMed ID: 17562565
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Activity of Lady's Mantle (Alchemilla vulgaris L.) Extracts against Orthopoxviruses.
Filippova EI
Bull Exp Biol Med; 2017 Jul; 163(3):374-377. PubMed ID: 28744637
[TBL] [Abstract][Full Text] [Related]
18. Foreword.
Shuto S
Chem Pharm Bull (Tokyo); 2018; 66(2):116. PubMed ID: 29386460
[No Abstract] [Full Text] [Related]
19. Synthesis and evaluation of 5'-modified 2'-deoxyadenosine analogues as anti-hepatitis C virus agents.
Ikejiri M; Ohshima T; Fukushima A; Shimotohno K; Maruyama T
Bioorg Med Chem Lett; 2008 Aug; 18(16):4638-41. PubMed ID: 18644724
[TBL] [Abstract][Full Text] [Related]
20. Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives.
Koyama J; Nisino Y; Morita I; Kobayashi N; Osakai T; Tokuda H
Bioorg Med Chem Lett; 2008 Jul; 18(14):4106-9. PubMed ID: 18556196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
